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Summary. Endothelin-1 (ET-1) is a 21-amino acid 
residue (ET-1[1-211) hypertensive peptide, which 
together with its receptor subtypes A and B (ETA and 
ETB) is expressed in the rat adrenal cortex, where it 
stimulates steroid-hormone (aldosterone and 
corticosterone) secretion through the ETB receptor and 
the growth (proliferative activity) of the zona 
glomerulosa (ZG) through the ETA receptor. ET-1[1-211 
is generated from bigET-1 by the endothelin-converting 
enzyme (ECE-1). However, recent evidence indicates 
the existence of an alternative chymase-mediated 
biosynthetic pathway leading to the production of an ET- 
1[1-311 peptide, which was found to reproduce the ETA 
receptor-mediated vascular effects of ET-l[l-211. We 
found that ET-1[1-211, but not ET-1[1-311, 
concentration-dependently raised steroid secretion from 
dispersed rat adrenocortical cells, its effect being 
blocked by the ETB-receptor selective antagonist BQ- 
788. Both ET-1s concentration-dependently increased 
the number of "S-phase" cells (as detected by the 5- 
bromo-2'-deoxyuridine immunocytochemical method) 
in capsule-ZG strips within a 240 min incubation. The 
ZG proliferogenic action of both ET-1s was blocked by 
the ETA-receptor antagonist BQ-123, and ET-l[l-311 
was found to be significantly more potent than ET-1[1- 
211. Autoradiography showed that in the rat adrenal ET- 
1[1-211 displaced the binding of selective ligands to both 
ETA ( [ 1 2 5 ~ ] ~ ~ - 1 5  1242) and ETB receptors ( [ 1 2 5 ~ ] ~ ~ -  
3020), while ET-l[l-311 eliminates only the binding to 
ETA receptors. Collectively, our findings provide strong 
evidence that ET-1[1-311 acts in the rat adrenal glands as 
a selective ETA-receptor agonist, mainly involved in the 
stimulation of ZG proliferative activity. 
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lntroduction 
Endothelin-1 (ET-1) is the prototype of a family of 
21-amino acid residue peptides, which act via two main 
receptor subtypes, named ETA and ETB. The 21-amino 
acid ET-1 (ET-l[l-211) is generated from big-ET-1 
through cleavage at the ~ r p ~ ~ - ~ a l / ~ l e ~ ~  bond by a 
specific endothelin-converting enzyme (ECE)-1 (for 
review, see Rubanyi and Polokoff, 1994). More recently, 
evidence has been provided that bi -ET-1 may also be 
selectively cleaved at the ~ ~ r ~ f ~ 1 ~ ~ ~  bond by a 
chymase to produce ET-1[1-311 (Nakano et al., 1997). 
ET-l[l-311 has been found to reproduce many of the 
vascular effects of ET-l[l-211, including contraction of 
porcine coronary artery and rat aorta (Kishi et al., 1998), 
and a rise in intracellular ca2+ concentration (Yoshizumi 
et al., 1998a, 1999; Inui et al., 1999) and proliferation 
rate of cultured human coronary smooth-muscle cells 
(Yoshizumi et al., 1998b). While the ET-l[l-211 
vasoconstrictor and proliferogenic effects are mainly 
ETA receptor-mediated (for review, see Miyauchi and 
Masaki, 1999), it was assumed that those of ET-1[1-311 
involve both ET-receptor subtypes, based on studies with 
the ETA-receptor antagonist BQ-485 and the ETB- 
receptor antagonist BQ-788 (Kishi et al., 1998). 
ET-l[l-211, which is locally produced in the adrenal 
glands, is deemed to act as an autocrine-paracrine 
regulator of adrenocortical-cell function (for review, see 
Nussdorfer et al., 1999). In the rat, ET-1[1-211 was 
found to stimulate the secretion and proliferation of 
adrenocortical cells, acting through ETB and ETA 
receptors, respectively (Belloni et al., 1996; Mazzocchi 
et al., 1997). No investigations are at present available 
on the effect of ET-l[l-311 on the rat adrenal cortex. It, 
therefore, seemed worthwhile to compare the in vitro 
effects of ET-l[l-211 and ET-l[l-311 on rat 
adrenocortical-cell function, and to study by 
autoradiography to which subtype of receptors ET-1 
binds in the rat adrenal gland. r i d r  
Materials and methods 
Reagents and animals 
ET-1[1-211, the selective ETA-receptor antagonist 
Endothelin- 1 and  adrenals 
BQ-123 and the ETB-receptor antagonist BQ-788 
(Ohlstein et al., 1996) were purchased from Neosystem 
Laboratories (Strasbourg, France), and ET-1[1-311 from 
Peptide Institute (Osaka, Japan). Medium 199 was 
obtained from Difco (Detroit, MI, USA), and the ECE-1 
inhibitor phosphoramidane (Loffler, 2000), 5-bromo-2'- 
deoxyuridine (BrdU), human serum albumin (HSA), and 
al1 other laboratory reagents were provided b Sigma 
Chemical Com any (St. Louis, MO, USA). [H511PD- z - 151242 and [l I]BQ 3020, which are selective ligands 
of ETA and ETB receptors (Ohlstein et al., 1996), were 
obtained from Amersham Laboratories (Aylesbury, UK). 
Adult male Sprague-Dawley rats (260230 g in body 
weight) were purchased from Charles-River (Como, 
Italy). The experimental protocol was approved by the 
local Ethical Committee for Animal Studies. 
Steroid-hormone secretion 
Rat adrenals were gently decapsulated to separate 
zona glomerulosa (ZG), and then halved and enucleated 
to eliminate medullary chromaffin cells. Dispersed ZG 
and zona fasciculata-reticularis (ZFJR) cells were 
obtained by collagenase digestion and mechanical 
disaggregation (Belloni et al., 1996). Medullary 
chromaffin-cell contamination of adrenocortical-cell 
preparations, as evaluated by phase microscopy, was 
virtually absent, and the viability of dispersed cells, as 
checked by the trypan blue-exclusion test, was higher 
than 92%. Dispersed cells were put in Medium 199 and 
Krebs-Ringer bicarbonate buffer with 0.2% glucose 
containing 5 mgImL HSA. They were incubated ( l d  
cellsJmL) with increasin concentrations of ET-1[1-211 
or ET-l[l-311 (from lo3' to lom7 M). Some sarnples 
were also incubated with ET-l[l-211 M) done and 
in the presence of 10-7 M BQ-123 or BQ-788. The 
incubation was carried out at 37 "C for 90 min in an 
atmosphere of 95% air-5% C02. At the end of the 
experiments, the incubation tubes were centrifuged and 
supematants were stored at -80 "C. 
Aldosterone and corticosterone were extracted from 
the incubation media and purified by HPLC (Mazzocchi 
et al., 1998), and their concentrations were measured by 
RIA, using the following commercial kits: ALDO-CTK2 
(IRE-Sorin, Vercelli, Italy; sensitivity, 5 pg/mL) and 
CRTX-RIA (Eurogenetix, Milan, Italy; sensitivity, 25 
pg/mL). Intra- and interassay variation coefficients were: 
aldosterone, 7.5% and 8.6%; and corticosterone, 6.1% 
and 7.8%, respectively. 
ZG cell DNA synthesís 
Capsule-ZG strips were obtained as described earlier 
(Bernet et al., 1994) and incubated with ET-1[1-211 or 
ET-l[l-311 (from 10-l1 to lom7 M); and ET-1[1-211 or 
ET-l[l-311 (10-l1 M) plus or without M BQ-123 , 
M BQ-788 or M phosphoramidone, in the 
presence of BrdU (20 mg/mL). The incubation was 
carried out at 37 "C for 240 min in an atmosphere of 
95% air-5% C02. According to Mazzocchi et al. (1997), 
the duration of the incubation being sufficient for ET- 
111-211 to exert its proliferogenic effect on the ZG cells 
of in situ perfused rat adrenals. At the end of the 
experiment, the strips were fixed in 4% para- 
formaldehyde and embedded in paraffin. BrdU-positive 
cells were detected by immunocytochemistry (Cell 
Proliferation ~ i t = " ; ~ m e r s h a m ) ,  and their number 
evaluated by counting 2,000 parenchymal cells in each 
sample. 
Autoradhgraphy 
Adrenal glands were immediately frozen at -30 OC 
by immersion in isopentane, and stored at -80 'C. Frozen 
sections (10-15 pm thick) were cut in a cryostat (Leitz 
1720 Digital) at -20 "C, and processed as previously 
detailed (Belloni et al., 1996). ETA and ETB receptors 
were labeled in vitro by incubation for 120 min at 37OC 
with 10-9 M [1251]p~-151242 or [ 1 2 5 ~ ] ~ ~ - 3 0 2 0 ,  
respectively. The following cold molecules were added 
to the incubation mixture at a concentration of M: 
ET-l[l-211, ET-l[l-311, BQ-123 and BQ-788. The 
reaction was stopped by washing the samples three times 
in 50 mM TrisIHC1 buffer. After rinsing, the sections 
were rapidly dried, fixed in paraformaldehyde vapors at 
80 "C for 120 min, and coated with NTB2 nuclear 
emulsion (Eastman Kodak, Rochester, NJ, USA). 
Autoradiographs were exposed for two weeks at 4 "C, 
and then developed with undiluted Kodak D19 
developer. They were stained with hematoxylin-eosin, 
and observed and photographed with a Leitz Laborlux 
microscope. 
Three unstained autoradiograms obtained from three 
adrenals were analyzed by computer-assisted 
densitometry with a camera-connected microscope and 
an IBM-compatible computer equipped with a software 
specifically written for this purpose (Studio Casti 
Imaging, Venice, Italy). For each autoradiogram, 10 
areas of ZG (about 36,000 pixels) were analyzed. The 
density value of the capsule was taken as the background 
value. 
Statistics 
Values were expressed as means 2 SEM of six 
(steroid secretion and DNA synthesis) or three 
(autoradiography) separate experiments. The statistical 
comparison of the results was done by ANOVA, 
followed by the Multiple Range Test of Duncan. 
Steroid-hormone secretion 
ET-l[l-211 concentration-dependently increased the 
production of both aldosterone and corticosterone from 
ZG and ZF/R cells, respectively. Minirnal and maximal 
effective concentrations were: aldosterone, 10-lo M and 
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1 0 - ~ / 1 0 - ~  M (1.4-fold and 2.1-fold rises); and ZG cell DNA synthesis 
corticosterone, M and l 0 - ~ / 1 0 - ~  M (2.1-fold and 
2.8-fold rises) (Fig. 1). The secretago e effect of 10-8 P Both ET-l[l-211 and ET-1[1-311 concentration- M ET-1[1-211 was annulled by 10- M BQ-788, and dependently raised the number of BrdU-positive cells in 
unaffected by M BQ-123 (Fig. 2). ET-1[1-311 did ZG strips, minimal and maximal effective concentrations 
not evoke any secretory response of dispersed rat being lo-'' and M, respectively. Despite the 
adrenocortical cells (Fig. 1). fact that the efficacy was the same (the maximal 
effective concentration of both ET-1s elicited an about 5- 
fold increase), the potency of ET-1[1-311 was higher 
than that of ET-l[l-211 (EC50: 0 .8+0 .1~10-~~  M versus 
7 .2+1 .0~10-~~  M; pe0.05) (Fig. 3). The effect of M 
ET-111-211 and ET-1[1-311 was blocked by 10-7 M BQ- 
123, and unaffected by either M BQ-788 or 10-4 M 
phosphoramidone (Fig. 4). 
Autoradiography 
As expected (Belloni et al., 1996, 1997), ETA 
receptors ( [ 1 2 5 ~ ] ~ ~ - 1 5 1 2 4 2  BQ-123- displaceable 
binding sites) were present in both ZG and adrenal 
medulla (Fig. 5 A,C), and ETB receptors ( [125~]~~-3020  
BQ-788-displaceable binding sites) in ZG, ZF/R and to a 
lesser extent in adrenal medulla (Fig. 5B,D). ET-1[1-211 
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eliminated either [ 1 2 5 ~ ] ~ ~ - 1 5 1 2 4 2  or [1251]~~-3020  
binding (data not shown), while ET-l[l-311 abolished 
[125~]~~-151242 binding, leaving unaffected [ 1 2 5 ~ ] ~ ~ -  
3020 binding (Fig. 5 E, F). Quantitative densitometry 
confirmed these qualitative descriptions, as far as ZG 
was concerned (Fig. 6). 
It is well demonstrated that ET-l[l-211, at variance 
with other peptides which stimulate adrenal steroid 
secretion and ZG proliferogenic activity only at high 
concentrations (Nussdorfer, 1996), exerts such effect at 
concentrations that are consistent with its possible 
physiological role (Nussdorfer et al., 1999). The present 
findings agree with this contention, because minimal and 
maximal effective concentrations are in the range of 
those that endogenous locally-produced ET-1[1-211 can 
conceivably reach in the adrenal gland (Nussdorfer et al., 
1999). They also confirm that in the rat adrenals, the ZG 
proliferogenic and secretagogue effect of ET-l[l-211 are 
mediated by the ETA- and ETB-receptor subtypes, 
respectively (Belloni et al., 1996; Mazzocchi et al., 
1997). In fact, they are selectively blocked by the ETA- 
receptor antagonist BQ-123 and the ETB-receptor 
antagonist BQ-788, respectively. 
ET-1[1-311 was found to mimic the ZG 
proliferogenic, but not the secretagogue effect of ET-1[1- 
211. The proliferogenic action of ET-1[1-311, like that of 
ET-1[1-211, is mediated by the ETA receptor subtype, 
Bdrü-positive cells [%] 1 
Fig. 3. Effects of ET-1[1-211 and ET-1[1-311 on the number of BrdU- 
positive cells in the ZG of rat adrenal glands. Data are means + SEM of 
six independent experiments. +: p<0.05, and *: p<0.01 from the 
respective baseline (B) value. 
inasmuch as it is blocked by BQ-123 and unaffected by 
BQ-788. The ECE-1 inhibitor phosphoramidone does 
not blunt the ZG proliferogenic action of ET-1[1-311, 
which indicates that this effect is not due to the cleavage 
of this peptide to ET-1[1-211, as reported to occur in 
cultured bronchial smooth muscle cells (Hayasaki- 
Kajiwara et al., 1999). This possibility is also made 
unlikely by the fact that ET-1[1-311 does not mimic the 
adrenocortical secretagogue effect of ET-l[l-211. Taken 
together, these findings would suggest that ET-l[l-311 is 
a selective agonist of ETA receptors, a possibility in 
keeping with the observation that although the ZG 
proliferogenic actions of the two ET-1s display similar 
efficacy, ET-1[1-311 is significantly more potent that ET- 
1[1-211. 
Our autoradiographic data provide strong support for 
this contention. In fact, besides confirming the currently 
accepted distribution of ETA and ETB receptors in rat 
adrenal gland (Belloni et al., 1996, 1997), they show 
that, at variance with ET-1[1-211, ET-1[1-311 dis laces 
the binding to ETA receptors of the ligand [12$)PD- 
151242, but not that to ETB receptors of the ligand 
[1251]~~-3020. 
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Fig. 4. Effects of 80-123 (10-7 M), BQ-788 (10-7 M) and 
phosphoramidone (PPR) (10-4 M) on the 10-8 M ET-1[1-211 or ET-l[l- 
311-induced increase in the number of BrdU-positive cells in the ZG of 
rat adrenal glands. Bars are means i SEM of six independent 
experiments. *: p<0.01 from the respective baseline value; A: p<0.01 
from the respective control (ET-1) value. 
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The chymase splitting big-ET-1 to ET-l[l-311 has depending upon the local needs, to the production of 
been detected in humans, but not yet in the rat tissues either ET-1[1-211 exerting both secretagogue and growth 
(Sanker et al., 1997). Hence, the endogenous production effects via the ETA and ETB receptors, or ET-1[1-311 
of ET-1[1-311 in the rat remains to be demonstrated. exclusively exerting a growth promoting effect via the 
However, our results raise the appealing possibility that ETA receptor. Be that as it may, our findings have a 
in the adrenal gland the post-translational alternative notable pharmacological relevance, because they seem 
cleavage of big-ET-1 by ECE-1 or chymase may lead, to provide the first demonstration of the existente of a 
Flg. 5. Autoradiograms of 
hernatoxylin-eosin-stained 
frozen sections of rat adrenal 
gland incubated with 10-0 M 
[125I]PD-151242 (A) or 104 M 
BQ-3020 (B). Binding of 
['251]PD-151242 tO ETA 
receptors is cornpletely 
displaced by 10-7 M BQ-123 
(C) and binding of [1251]BQ- 
3020 is eliminated by 10-7 M 
BQ-788 (D). ET-1 [l -311 (10-7 
M) eliminated binding to ETA 
receptors (E), without altering 
binding to ETB receptors (F). 
c: gland capsule; AM: adrenal 
rnedulla; v: medullary blood 
vessels. x 80 
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Flg. 6. Evaluation by quantitative densitometry of 10-9 M [125l]PD- 
151242 or 10-9 M [1251]BQ-3020 binding in the rat ZG (total binding, TB), 
and of its displacement by 10-7 M BQ-123, BQ-788, ET-1 [l-211 and ET- 
1[1-311. Bars are means I SEM of three independent experiments. 
*: p<0.01 hom the respective background (BG) value; A: pe0.01 from the 
respective TB value. 
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